Trials / Completed
CompletedNCT06046352
Symptom Burden Guiding Invasive Electrophysiological Study in Paroxysmal Supraventricular Tachycardia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 711 (actual)
- Sponsor
- Hospital Universitario 12 de Octubre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
BELIEVE-SVT is a European multi-centre, retrospective registry in tertiary hospitals performing electrophysiological study in patients with palpitations considered clinically suggestive of paroxysmal supraventricular tachycardia by a cardiologist and without electrocardiographic documentation of tachycardia or preexcitation. Clinical characteristics, results of electrophysiological study and ablation, complications, and clinical outcomes during follow-up will be analysed.
Detailed description
The "Symptom Burden As Guiding Principle For Invasive Electrophysiological Study In Paroxysmal Supraventricular Tachycardia (Believe-SVT)" study was a multi-centre, retrospective, observational registry carried out in tertiary European hospitals. Inclusion criteria were: symptoms that were considered suggestive of paroxysmal supraventricular tachycardia by a cardiologist and/or cardiac electrophysiologist; absence of any sort of electrocardiographic tracing during episodes (including wearables and other single lead devices), and having undergone an electrophysiological study aimed at the diagnosis of paroxysmal supraventricular tachycardia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Electrophysiological study (and ablation when appropriate) | Electrophysiological study (and ablation when appropriate) |
Timeline
- Start date
- 2019-12-17
- Primary completion
- 2021-11-02
- Completion
- 2022-06-01
- First posted
- 2023-09-21
- Last updated
- 2023-09-21
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06046352. Inclusion in this directory is not an endorsement.